The social and economic burdens of HIV in the Russian Federation


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Despite the measures taken to fight the HIV infection epidemic, the incidence, prevalence, and mortality rates of the disease in Russia are higher than those in other countries of Eastern and Central Europe. This leads to negative consequences that go beyond the healthcare system and retards the further socioeconomic development of our country. Objective. To estimate the social and economic burdens of the spread of HIV infection in Russia. Materials and methods. When estimating the burden, the negative effects and costs associated with the spread of HIV infection in Russia as of 2019 were taken into account. The social burden of HIV infection was measured by the contribution of the disease to increased mortality rates, decreased life expectancy at birth, by fertility, natality, and population size. To estimate the burden, a difference was calculated between the actual values of the 2019 indicators and the hypothetical scenario proposing that there was no spread of HIV in Russia. To quantify the economic burden, allowance was made for the direct state medical costs of screening for, diagnosis, and treatment of HIV infection, including antiretroviral therapy expenditures; for direct non-medical costs for the payment of pensions and disability benef its, as well as for indirect costs as the lost output of goods and services due to premature mortality and disability. Results. As of 2019, the spread of HIV infection in Russia resulted in additional 19,941 deaths and declined birth rates by 5,845 children. Life expectancy at birth became lower by 0.31 years. The negative contribution of HIV infection to the natural growth of population was 25,786persons whereas that to the average annual population size was 12,893. The total economic burden of HIV infection was estimated at 220.1 billion rubles, or about 0.2% of GDP. Indirect economic costs made up the bulk of the expenses (172.7 billion rubles, or 78.4%). The second component of the expenses was direct medical costs (34.6 billion rubles, or 15.7%). Conclusion. The obtained estimates of the social aeconomic burden of HIV infection in Russia are significant, which requires the improvement of measures to fight this disease.

Texto integral

Acesso é fechado

Sobre autores

Nikolai Avksentiev

Financial Research Institute, Ministry of Finance of Russia; Russian Presidential Academy of National Economy and Public Administration

Email: na@nifi.ru
Advisor to the Director, Financial Research Institute, Ministry of Finance of Russia, Researcher, Institute of Applied Economic Research

Aleksandr Makarov

Interregional Public Organization «Association of Clinical Pharmacologists»

Email: alex@makarov.su
Consultant

Yulia Makarova

Financial Research Institute, Ministry of Finance of Russia

Email: makarova@nifi.ru
Cand. Economic Sci

Ekaterina Pazukhina

Financial Research Institute, Ministry of Finance of Russia; Russian Presidential Academy of National Economy and Public Administration

Email: epazukhina@nifi.ru
Junior Researcher

Natalya Sisigina

Financial Research Institute, Ministry of Finance of Russia; Russian Presidential Academy of National Economy and Public Administration

Email: sisigina@nifi.ru
Junior Researcher

Olesya Feoktistova

Financial Research Institute, Ministry of Finance of Russia

Email: feoktistova@nifi.ru
Head, Center for Social Sphere Finance

Elena Zaitseva

GlasgoSmithKlein Trading

Email: elena.x.zaytseva@gsk.com
Healthcare and Patient Relations Manager

Sergey Kuznetsov

GlasgoSmithKlein Trading

Email: sergey.d.kuznetsov@viivhealthcare.com
Candidate of Medical Sciences, Medical Research Expert

Alistair Pace

ViiV Healthcare

Strategy and Implementation Supervisor, Medical Department

Kamil Saitkulov

GlasgoSmithKlein Trading

Email: kamil.i.saytkulov@gsk.com
Head, Office of Communications and Government Relations

Bibliografia

  1. Joint United Nations Programme on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva, 2014.
  2. UNAIDS. Understanding fast-track. Accelerating action to end the AIDS epidemic by 2030. 2015. https://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_en.pdf
  3. Global AIDS Update - Seizing the moment - Tackling entrenched inequalities to end epidemics, 2020. https://www.unaids.org/en/resources/documents/2020/global-aids-report
  4. Справка. ВИЧ-инфекция в Российской Федерации на 31 декабря 2020 г. http://www.hivrussia.info/wp-content/uploads/2021/03/VICH-infektsiya-v-Rossijskoj-Federatsii-na-31.12.2020-.pdf
  5. HIV/AIDS surveillance in Europe 2019-2018 data. uropean Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2019-2018-data
  6. UNAIDS. Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic, 2021. https://www.unaids.org/en/resources/documents/2021/UNAIDS_FactSheet
  7. HIV ESTIMATES WITH UNCERTAINTY BOUNDS 1990 2019. UNAIDS. http://www.unaids.org/sites/default/files/media_asset/HIV_estimates_from_1990-to-present.xlsx
  8. Уточненный годовой отчет за 2018 год о ходе реализации пилотной государственной программы Российской Федерации «Развитие здравоохранения» и об оценке ее эффективности. https://static2.rosminzdrav.ru/system/attachments/attaches/тыс./045/232/original
  9. Уточненный_отчет_о_реализации_ГП_за_2018_год.pdf?1561020926
  10. Коалиция по готовности к лечению: Анализ закупок АРВ-препаратов в Российской Федерации в 2019 год. https://itpcru.org/wpcontent/uploads/2020/04/itpcruotchet-arv-preparaty-2019-28.04.20-final_prep.pdf
  11. Клинические рекомендации «ВИЧ-инфекция у взрослых». 2017 http://rushiv.ru/category/docs/national-recs/kr-17/?ysclid=l5wajbcvxu 641077258
  12. Клинические рекомендации «Туберкулез у взрослых». 2020. https://cr.minzdrav.gov.ru/recomend/16_1
  13. Оганов Р.Г., Концевая А.В., Калинина А.М. Экономический ущерб от сердечно-сосудистых заболеваний в Российской Федерации. Кардиоваскулярная терапия и профилактика 2011; 10 (4): 4-9
  14. Авксентьева М.В., Горкавенко Ф.В., Никитина А.В.. Савилова А.Г., Герасимова К.В., Мусина Н.З. и др. Оценка социально-экономического бремени рака легко го в Российской Федерации. Медицинские технологии. Оценка и выбор 2018; 4(34): 63-75. doi: 10.31556/22190678.2018.34.4.063-075

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2022

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies